Merck Gets a Shot of Confidence From Pivotal Test of SubQ Injectable Keytruda
| DREQX Fund | USD 21.94 0.12 0.55% |
Slightly above 52% of Dreyfus Research's investor base is interested to short. The analysis of overall sentiment of trading Dreyfus Research Growth mutual fund suggests that many investors are impartial at this time. Dreyfus Research's investing sentiment can be driven by a variety of factors including economic data, Dreyfus Research's earnings reports, geopolitical events, and overall market trends.
Dreyfus |
Merck said topline Phase 3 results show an injectable version of Keytruda met the main goal of non-inferiority compared to the intravenously infused formulation that is the pharma giants top-selling product. Injectable Keytruda could help Merck compete against coming competition from biosimilars.
Read at medcitynews.com
 |
Dreyfus Research Fundamental Analysis
We analyze Dreyfus Research's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus Research using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus Research based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
One Year Return
One Year Return Comparative Analysis
Dreyfus Research is currently under evaluation in one year return among similar funds. One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Dreyfus Research Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus Research mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus Research could also be used in its relative valuation, which is a method of valuing Dreyfus Research by comparing valuation metrics with similar companies.
Peers
Dreyfus Research Related Equities
| AUUIX | Ab Select | 0.50 | ||||
| GCIEX | The Gabelli | 0.50 | ||||
| MFIRX | Ms Global | 0.19 | ||||
| IEQAX | Icon Equity | 0.17 | ||||
| DIVHX | Cutler Equity | 0.03 | ||||
| HULEX | Huber Capital | 0.17 |
Other Information on Investing in Dreyfus Mutual Fund
Dreyfus Research financial ratios help investors to determine whether Dreyfus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus with respect to the benefits of owning Dreyfus Research security.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |